These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5001942)

  • 21. Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis.
    Pitcher-Wilmott RW; Levinsky RJ; Matthew DJ
    Arch Dis Child; 1982 Aug; 57(8):577-81. PubMed ID: 6810763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dys-gammaglobulinemia and infectious asthma.
    Ghory JE
    J Asthma Res; 1971 Sep; 9(1):37-40. PubMed ID: 5133860
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.
    Speert DP; Wong SY; Macdonald M; Sargeant R
    Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    Arch Dis Child; 1990 Mar; 65(3):259-63. PubMed ID: 2110441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    Arch Dis Child; 1986 Nov; 61(11):1114-20. PubMed ID: 3098186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of Pseudomonas aeruginosa with immunoglobulins and complement in sputum.
    Hann S; Holsclaw DS
    Infect Immun; 1976 Jul; 14(1):114-7. PubMed ID: 820637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opsonic activity of blister fluid from burn patients.
    Deitch EA
    Infect Immun; 1983 Sep; 41(3):1184-9. PubMed ID: 6411619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic aspects of cystic fibrosis.
    Döring G; Albus A; Høiby N
    Chest; 1988 Aug; 94(2 Suppl):109S-115S. PubMed ID: 3135159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of antibody in infections due to Pseudomonas aeruginosa.
    Young LS
    J Infect Dis; 1974 Nov; 130 Suppl(0):S111-8. PubMed ID: 4213568
    [No Abstract]   [Full Text] [Related]  

  • 31. Opsonin-independent phagocytosis of surface-adherent bacteria by human alveolar macrophages.
    Lee DA; Hoidal JR; Garlich DJ; Clawson CC; Quie PG; Peterson PK
    J Leukoc Biol; 1984 Dec; 36(6):689-701. PubMed ID: 6438262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis.
    Pier GB; Coleman F; Grout M; Franklin M; Ohman DE
    Infect Immun; 2001 Mar; 69(3):1895-901. PubMed ID: 11179370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis.
    Van Bever HP; Gigase PL; De Clerck LS; Bridts CH; Franckx H; Stevens WJ
    Arch Dis Child; 1988 Oct; 63(10):1222-8. PubMed ID: 3143315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase.
    Bainbridge T; Fick RB
    J Lab Clin Med; 1989 Dec; 114(6):728-33. PubMed ID: 2512365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of an octavalent Pseudomonas aeruginosa conjugate vaccine in plasma donors and in bone marrow transplant and cystic fibrosis patients.
    Cryz SJ; Fürer E; Que JU; Sadoff JC; Brenner M; Schaad UB
    Antibiot Chemother (1971); 1991; 44():157-62. PubMed ID: 1801634
    [No Abstract]   [Full Text] [Related]  

  • 37. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
    Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
    N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.
    Penketh AR; Pitt TL; Hodson ME; Batten JC
    J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement by tumor necrosis factor-alpha of Fc alpha receptor expression and IgA-mediated superoxide generation and killing of Pseudomonas aeruginosa by polymorphonuclear leukocytes.
    Hostoffer RW; Krukovets I; Berger M
    J Infect Dis; 1994 Jul; 170(1):82-7. PubMed ID: 8014525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM; Losowsky MS
    J Clin Pathol; 1986 Oct; 39(10):1124-9. PubMed ID: 3097080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.